Shore Capital view: Creo Medical (‘CREO’) is at a commercial inflection point. In FY25, sales of its surgical endoscopy tools grew substantially (+50%) despite a tightening cost base (-20%), establishing that
RNS Hotlist with Zak Mir: KAV, KEFI, TOO, AAI, VULT, SNOX, GEO, IMM, CGO, GROW, GMET, NTVO, HAYD, POW & STJ
Yesterday Kavango Resources (KAV) advised that Mr Ben Turney is leaving his position as CEO, and as a Director of the Company, with immediate effect. Mr Peter Wynter Bee, Executive Chairman will